The Patent Finder

Capricor, Inc.

6 patents currently held · Updated Nov 22, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2033
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 6, 2027
    The maintenance fee for Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy (US 10,369,173) comes due Feb 6, 2027. Unpaid by Aug 6, 2027, it lapses early.
  • 1 fee due Mar 19, 2027
    The maintenance fee for Methods and Compositions for Treating Skeletal Muscular Dystrophy (US 11,759,482) comes due Mar 19, 2027. Unpaid by Sep 20, 2027, it lapses early.
  • 1 fee due Apr 30, 2027
    The maintenance fee for Methods of treating ocular inflammation and chemical injuries of the eye with extracellular vesicles (US 11,801,268) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 6 of 6

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,369,173Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
In force
 · USPTO record
In forceUSPTO record
US 9,884,076Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
In force
 · USPTO record
In forceUSPTO record
US 10,695,293Method of preventing or treating radiation-induced dermatitis with extracellular vesicles
In force
 · USPTO record
In forceUSPTO record
US 11,801,268Methods of treating ocular inflammation and chemical injuries of the eye with extracellular vesicles
In force
 · USPTO record
In forceUSPTO record
US 11,529,376Methods of treating systemic graft-versus-host disease with extracellular vesicles
In force
 · USPTO record
In forceUSPTO record
US 11,759,482Methods and Compositions for Treating Skeletal Muscular Dystrophy
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 6: 1 patent in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

11 pending · 2 abandoned · 4 no status recorded

Showing 1 to 10 of 17, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/191,968Cell Therapy Compositions and Methods of ManufactureApr 28, 2025Pending
19/061,766Activation-Induced Tissue-Effector Cells Suitable for Cell Therapy and Extracelluar Vesicles Derived TherefromFeb 24, 2025Pending
18/920,959Arginase Bearing Vesicle Composition and Method of UseOct 20, 2024Pending
18/786,287Targeted Vesicle Compositions and MethodsJul 26, 2024Pending
18/205,313Methods and Compositions for Treating Skeletal Muscular DystrophyJun 2, 2023Pending
17/983,797Nov 9, 2022No status recorded
18/690,177Exosomal Nucleic Acid Vaccine Composition for Protection Against SARS-COV-2 Infection and DiseaseSep 12, 2022Pending
18/577,642Method for Surface Expression of Membrane Proteins That Have a Cytoplasmic C-Terminal TailJul 8, 2022Pending
18/037,478Extracellular Vesicles Derived from Cardiosphere-Derived Cells as Anti-Shock TherapeuticsNov 23, 2021Pending
18/011,041Extracellular Vesicles Engineered to Be Loaded with Distinct RNA Cargo for Improved Therapeutic EfficacyJun 29, 2021Pending
10 of 17 applications shown.
Pro members see all 17 published applications.
Pro members: see all 17 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited